Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03735797 · ClinicalTrials.gov registry record
Cancer Stem Cells in Acute Leukemia
A clinical trial of Acute Leukemia, sponsored by Sanford Health.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT03735797 is a study of Acute Leukemia that is active but no longer recruiting, run by Sanford Health. The registered enrollment target is 50 participants, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03735797, a study of Acute Leukemia, is active but no longer recruiting, sponsored by Sanford Health.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bone marrow aspirate or peripheral blood sample collection
Study Locations (1)
North Dakota
- Sanford - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-07-12 |
| Est. Completion | 2029-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03735797
The ClinicalTrials.gov registry entry for NCT03735797 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower). The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Bone marrow aspirate or peripheral blood sample collection is the first listed.
NCT03735797 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.
Frequently Asked Questions
What is clinical trial NCT03735797 about?
NCT03735797 is a clinical study titled "Cancer Stem Cells in Acute Leukemia". Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.
What is the current status of trial NCT03735797?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2017-07-12. Estimated completion is 2029-03-01.
What conditions does trial NCT03735797 study?
This clinical trial studies the following conditions: Acute Leukemia.
What interventions are being tested in trial NCT03735797?
The interventions under investigation include: Bone marrow aspirate or peripheral blood sample collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03735797?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03735797 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
RECRUITING · Phase 2
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
RECRUITING · Phase 2
-
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
RECRUITING · Phase 1
-
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
RECRUITING · Phase 2
-
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.